论文部分内容阅读
肝纤维化是慢性肝病的共同病理改变,它不仅是慢性肝病向肝硬化发展的必经之路,而且贯穿于肝硬化的始终,甚至发展到肝癌。因此,对肝纤维化的研究已经成为目前我国乃至全世界研究的热门课题,以期阻断肝硬化和肝癌的发生,延缓疾病进程。对肝纤维化的治疗目前尚无特效药,近年研究显示中医药在肝纤维化的治疗方面具有很大优势,现主要对肝纤维化的发病机制、扛板归的成分、功能及扛板归与肝纤维化的关系等研究进展予以综述。
Liver fibrosis is a common pathological change of chronic liver disease. It is not only the only way for the development of chronic liver disease to cirrhosis, but also runs through cirrhosis and even to liver cancer. Therefore, the study of liver fibrosis has become a hot topic in our country and the world at present, in order to block the occurrence of liver cirrhosis and liver cancer and delay the disease process. The treatment of liver fibrosis is currently no cure, in recent years, studies have shown that traditional Chinese medicine in the treatment of liver fibrosis has a great advantage, is mainly the pathogenesis of liver fibrosis, carry plate composition, function and carry plate And the relationship between liver fibrosis and other research advances to be reviewed.